Touchstone International Medical Science Co Ltd (688013) — Cash Flow Reinvestment Rate
Touchstone International Medical Science Co Ltd (688013) has a Cash Flow Reinvestment Rate of 0.31x as of September 2025, reinvesting CN¥8.28 Million (capex CN¥8.28 Million ) from operating cash flow of CN¥27.05 Million. Check 688013 cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Touchstone International Medical Science Co Ltd Cash Flow Reinvestment Rate (2017–2024)
Historical reinvestment intensity for Touchstone International Medical Science Co Ltd across 8 annual periods. Explore Touchstone International Medical Science (688013) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Touchstone International Medical Science Co Ltd (2017–2024)
Year-by-year capital reinvestment analysis for Touchstone International Medical Science Co Ltd. For live market cap and broader valuation context, see market value of Touchstone International Medical Science.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 2.92x | CN¥155.74 Million | CN¥53.41 Million | CN¥41.94 Million | ▲ +107.8% |
| 2023 | 1.40x | CN¥116.38 Million | CN¥82.95 Million | CN¥18.41 Million | ▼ -8.0% |
| 2022 | 1.53x | CN¥76.90 Million | CN¥50.40 Million | CN¥47.67 Million | ▼ -15.3% |
| 2021 | 1.80x | CN¥109.80 Million | CN¥60.98 Million | CN¥9.21 Million | ▼ -71.3% |
| 2020 | 6.28x | CN¥264.40 Million | CN¥42.08 Million | CN¥7.29 Million | ▲ +1329.7% |
| 2019 | 0.44x | CN¥15.30 Million | CN¥34.82 Million | CN¥9.41 Million | ▼ -27.2% |
| 2018 | 0.60x | CN¥20.78 Million | CN¥34.44 Million | CN¥20.78 Million | ▼ -68.7% |
| 2017 | 1.93x | CN¥15.21 Million | CN¥7.88 Million | CN¥15.21 Million | — |